4: Statement of changes in beneficial ownership of securities-Director Burt Carol
May 1 07:02
4: Statement of changes in beneficial ownership of securities-Director Drexler Karen
May 1 02:21
144: Notice of proposed sale of securities pursuant to Rule 144
Apr 30 02:59
10-Q: Quarterly report
Apr 27 03:59
8-K: ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
Apr 26 04:14
ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Rider Michael J
Mar 7 09:50
ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Rider Michael J
Mar 5 08:16
ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 5 06:58
ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 2 06:12
ResMed | 4: Statement of changes in beneficial ownership of securities-Director FARRELL PETER C
Feb 24 07:45
ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 23 10:43
ResMed | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(12.56%)
Feb 14 11:37
ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 7 00:27
ResMed | 10-Q: Quarterly report
Jan 26 04:36
ResMed | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.7%)
Jan 26 02:50
ResMed | 8-K: ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
Jan 25 05:12
ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Douglas Robert Andrew
Jan 3 13:00
ResMed | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Sandercock Brett
Nov 30, 2023 08:45
ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 28, 2023 06:26
ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Rider Michael J
Nov 28, 2023 05:33
No Data
No Data